{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:13:00Z","timestamp":1792782780955,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Padova","id":[{"id":"https:\/\/ror.org\/00240q980","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Paediatric type 1 diabetes (T1D) is a chronic disease that represents a global public health concern. Italian data describing epidemiology, comorbidity burden, and healthcare resource utilisation (HCRU) of paediatric T1D remain fragmented, mostly deriving from regional registries or limited cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective observational analysis was conducted using Italian administrative databases corresponding to ~\u200912,000,000 individuals. Patients with T1D aged\u2009&lt;\u200918 years were identified during 2010\u20132023 using diagnostic proxies (insulin prescriptions or diabetes-related hospitalisations). Epidemiological analyses were restricted to healthcare entities with continuous data availability during 2018\u20132022. Demographic and clinical characteristics were evaluated at baseline. Comorbidity onset, HCRU, and direct costs were assessed during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3,220 paediatric patients with T1D were identified. Between 2018 and 2022, T1D incidence increased from 16.4 to 22.4 cases\/100,000 individuals aged\u2009&lt;\u200918 years (compound annual growth rate [CAGR]\u2009+\u20098.1%), while the prevalence reached 256 cases\/100,000 in 2022 (CAGR\u2009+\u200910.0%). Most patients had minimal comorbidity at diagnosis. During follow-up, autoimmune conditions were the most common comorbidities, especially thyroid (8.9%) and coeliac disease (6.0%), often emerging within the first year post-diagnosis.<\/jats:p>\n                    <jats:p>HCRU was the highest during the first year, with frequent diabetes-related hospitalisations and prescriptions of diabetes medications. Hospitalisation-related costs declined, whereas pharmaceutical costs increased over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Paediatric T1D is an expanding chronic condition in Italy, characterised by early clustering of autoimmune comorbidities and substantial healthcare utilisation at diagnosis. These findings highlight the need for structured surveillance and coordinated care pathways to support long-term management and healthcare planning.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00592-026-02776-4","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T07:17:34Z","timestamp":1787296654000},"page":"1959-1968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increasing incidence and clinical burden of paediatric type 1 diabetes in Italy: insights from a large administrative database"],"prefix":"10.1007","volume":"63","author":[{"given":"Enza","family":"Mozzillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Buzzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Candido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basilio","family":"Pintaudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Degli Esposti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Leogrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Capodaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Fousteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6510-2097","authenticated-orcid":false,"given":"Gian Paolo","family":"Fadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"2776_CR1","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41390-024-03107-5","volume":"97","author":"B Gong","year":"2025","unstructured":"Gong B, Yang W, Xing Y et al (2025) Global, regional, and national burden of type 1 diabetes in adolescents and young adults. Pediatr Res 97:568\u2013576. https:\/\/doi.org\/10.1038\/s41390-024-03107-5","journal-title":"Pediatr Res"},{"key":"2776_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.16501","volume":"27","author":"KJ Bell","year":"2025","unstructured":"Bell KJ, Lain SJ (2025) The Changing Epidemiology of Type 1 Diabetes: A Global Perspective. Diabetes Obes Metabolism 27:3\u201314. https:\/\/doi.org\/10.1111\/dom.16501","journal-title":"Diabetes Obes Metabolism"},{"key":"2776_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S2213-8587(23)00025-6","volume":"11","author":"LE Wagenknecht","year":"2023","unstructured":"Wagenknecht LE, Lawrence JM, Isom S et al (2023) Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002\u201318: results from the population-based SEARCH for Diabetes in Youth study. Lancet Diabetes Endocrinol 11:242\u2013250. https:\/\/doi.org\/10.1016\/S2213-8587(23)00025-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2776_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","volume":"10","author":"GA Gregory","year":"2022","unstructured":"Gregory GA, Robinson TIG, Linklater SE et al (2022) Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol 10:741\u2013760. https:\/\/doi.org\/10.1016\/S2213-8587(22)00218-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2776_CR5","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.2337\/db25-2118-LB","volume":"74","author":"R Buzzetti","year":"2025","unstructured":"Buzzetti R, Candido R, Cherubini V et al (2025) 2118-LB: Administrative Italian Diabetes Analysis (AIDA) on Epidemiology and Economic Burden of Type 1 Diabetes in Pediatric Patients. Diabetes 74:2118\u2013LB. https:\/\/doi.org\/10.2337\/db25-2118-LB","journal-title":"Diabetes"},{"key":"2776_CR6","doi-asserted-by":"publisher","first-page":"109020","DOI":"10.1016\/j.diabres.2021.109020","volume":"179","author":"C Maffeis","year":"2021","unstructured":"Maffeis C, Mancioppi V, Piona C et al (2021) Type 1 diabetes prevalence and incidence rates in the pediatric population of Veneto Region (Italy) in 2015\u20132020. Diabetes Res Clin Pract 179:109020. https:\/\/doi.org\/10.1016\/j.diabres.2021.109020","journal-title":"Diabetes Res Clin Pract"},{"key":"2776_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7239692","volume":"2016","author":"F Fortunato","year":"2016","unstructured":"Fortunato F, Cappelli MG, Vece MM et al (2016) Incidence of Type 1 Diabetes among Children and Adolescents in Italy between 2009 and 2013: The Role of a Regional Childhood Diabetes Registry. J Diabetes Res 2016:1\u20137. https:\/\/doi.org\/10.1155\/2016\/7239692","journal-title":"J Diabetes Res"},{"key":"2776_CR8","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1111\/dom.15024","volume":"25","author":"R Gesuita","year":"2023","unstructured":"Gesuita R, Rabbone I, Marconi V et al (2023) Trends and cyclic variation in the incidence of childhood type 1 diabetes in two Italian regions over 33 years and during the COVID -19 pandemic. Diabetes Obes Metabolism 25:1698\u20131703. https:\/\/doi.org\/10.1111\/dom.15024","journal-title":"Diabetes Obes Metabolism"},{"key":"2776_CR9","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.numecd.2016.09.002","volume":"26","author":"G Bruno","year":"2016","unstructured":"Bruno G, Pagano E, Rossi E et al (2016) Incidence, prevalence, costs and quality of care of type 1 diabetes in Italy, age 0\u201329 years: The population-based CINECA-SID ARNO Observatory, 2002\u20132012. Nutr Metabolism Cardiovasc Dis 26:1104\u20131111. https:\/\/doi.org\/10.1016\/j.numecd.2016.09.002","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"2776_CR10","doi-asserted-by":"publisher","first-page":"111750","DOI":"10.1016\/j.diabres.2024.111750","volume":"213","author":"C Ripoli","year":"2024","unstructured":"Ripoli C, Ricciardi MR, Angelo MR et al (2024) Incidence of type 1 diabetes in Sardinian children aged 0\u201314 years has almost doubled in the last twenty years. On top of the world. Diabetes Res Clin Pract 213:111750. https:\/\/doi.org\/10.1016\/j.diabres.2024.111750","journal-title":"Diabetes Res Clin Pract"},{"key":"2776_CR11","doi-asserted-by":"publisher","first-page":"10012","DOI":"10.3390\/ijms241210012","volume":"24","author":"E Kawasaki","year":"2023","unstructured":"Kawasaki E (2023) Anti-Islet Autoantibodies in Type 1 Diabetes. IJMS 24:10012. https:\/\/doi.org\/10.3390\/ijms241210012","journal-title":"IJMS"},{"key":"2776_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/dom.16460","volume":"27","author":"F Mauvais","year":"2025","unstructured":"Mauvais F, Van Endert PM (2025) Type 1 Diabetes: A Guide to Autoimmune Mechanisms for Clinicians. Diabetes Obes Metabolism 27:40\u201356. https:\/\/doi.org\/10.1111\/dom.16460","journal-title":"Diabetes Obes Metabolism"},{"key":"2776_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11892-016-0738-2","volume":"16","author":"V Lampasona","year":"2016","unstructured":"Lampasona V, Liberati D (2016) Islet Autoantibodies. Curr Diab Rep 16:53. https:\/\/doi.org\/10.1007\/s11892-016-0738-2","journal-title":"Curr Diab Rep"},{"key":"2776_CR14","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyz034","volume":"48","author":"A Wolf","year":"2019","unstructured":"Wolf A, Dedman D, Campbell J et al (2019) Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int J Epidemiol 48:1740\u20131740. https:\/\/doi.org\/10.1093\/ije\/dyz034. g","journal-title":"Int J Epidemiol"},{"key":"2776_CR15","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1111\/dom.16454","volume":"27","author":"SV Edelman","year":"2025","unstructured":"Edelman SV, Agardh D, Cui N et al (2025) Risk of new-onset type 1 diabetes in individuals with celiac disease and thyroid disease\u2014An observational study. Diabetes Obes Metabolism 27:4229\u20134238. https:\/\/doi.org\/10.1111\/dom.16454","journal-title":"Diabetes Obes Metabolism"},{"key":"2776_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-16","author":"E Muggah","year":"2013","unstructured":"Muggah E, Graves E, Bennett C, Manuel DG (2013) BMC Public Health 13:16. https:\/\/doi.org\/10.1186\/1471-2458-13-16. Ascertainment of chronic diseases using population health data: a comparison of health administrative data and patient self-report"},{"key":"2776_CR17","doi-asserted-by":"publisher","first-page":"e113741","DOI":"10.1371\/journal.pone.0113741","volume":"9","author":"L Scalone","year":"2014","unstructured":"Scalone L, Cesana G, Furneri G et al (2014) Burden of Diabetes Mellitus Estimated with a Longitudinal Population-Based Study Using Administrative Databases. PLoS ONE 9:e113741. https:\/\/doi.org\/10.1371\/journal.pone.0113741","journal-title":"PLoS ONE"},{"key":"2776_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12902-023-01316-3","volume":"23","author":"SAG de Vries","year":"2023","unstructured":"de Vries SAG, Bak JCG, Verheugt CL et al (2023) Healthcare expenditure and technology use in pediatric diabetes care. BMC Endocr Disord 23:72. https:\/\/doi.org\/10.1186\/s12902-023-01316-3","journal-title":"BMC Endocr Disord"},{"key":"2776_CR19","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.18553\/jmcp.2020.26.11.1399","volume":"26","author":"JC Simeone","year":"2020","unstructured":"Simeone JC, Shah S, Ganz ML et al (2020) Healthcare resource utilization and cost among patients with type 1 diabetes in the United States. JMCP 26:1399\u20131410. https:\/\/doi.org\/10.18553\/jmcp.2020.26.11.1399","journal-title":"JMCP"},{"key":"2776_CR20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12933-021-01338-y","volume":"20","author":"ML Morieri","year":"2021","unstructured":"Morieri ML, Perrone V, Veronesi C et al (2021) Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets\u2019 attainment in subjects with and without type 2 diabetes. Cardiovasc Diabetol 20:144. https:\/\/doi.org\/10.1186\/s12933-021-01338-y","journal-title":"Cardiovasc Diabetol"},{"key":"2776_CR21","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/pedi.13427","volume":"23","author":"F Sundberg","year":"2022","unstructured":"Sundberg F, deBeaufort C, Krogvold L et al (2022) ISPAD Clinical Practice Consensus Guidelines 2022: Managing diabetes in preschoolers. Pediatr Diabetes 23:1496\u20131511. https:\/\/doi.org\/10.1111\/pedi.13427","journal-title":"Pediatr Diabetes"},{"key":"2776_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","volume":"19","author":"MJ Redondo","year":"2023","unstructured":"Redondo MJ, Morgan NG (2023) Heterogeneity and endotypes in type 1 diabetes mellitus. Nat Rev Endocrinol 19:542\u2013554. https:\/\/doi.org\/10.1038\/s41574-023-00853-0","journal-title":"Nat Rev Endocrinol"},{"key":"2776_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"2776_CR24","doi-asserted-by":"publisher","first-page":"e15084","DOI":"10.1111\/ped.15084","volume":"64","author":"Z Ergenc","year":"2022","unstructured":"Ergenc Z, Kepenekli E, \u00c7etin E et al (2022) Incidence of multisystem inflammatory syndrome in children and the comorbidity scores in pediatric coronavirus disease 2019 cases. Pediatr Int 64:e15084. https:\/\/doi.org\/10.1111\/ped.15084","journal-title":"Pediatr Int"},{"key":"2776_CR25","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1080\/13696998.2025.2525002","volume":"28","author":"J Yang","year":"2025","unstructured":"Yang J, Tamberou C, Arnee E et al (2025) Quantifying all-cause healthcare resource utilization and costs of children with mild-to-moderate long COVID in France. J Med Econ 28:1002\u20131013. https:\/\/doi.org\/10.1080\/13696998.2025.2525002","journal-title":"J Med Econ"},{"key":"2776_CR26","doi-asserted-by":"publisher","unstructured":"Tiwari BB, Hall DB, Shin E et al (2026) Existing Geographical Disparities in the Utilization of Counseling Services by Pediatric Patients with Obesity. Child Obes 21532176261471297. https:\/\/doi.org\/10.1177\/21532176261471297","DOI":"10.1177\/21532176261471297"},{"key":"2776_CR27","unstructured":"Epicentro (2014) Istituto Superiore di Sanit\u00e0. Diabete di tipo 1 in et\u00e0 evolutiva"},{"key":"2776_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13052-022-01264-z","volume":"48","author":"S Passanisi","year":"2022","unstructured":"Passanisi S, Salzano G, Aloe M et al (2022) Increasing trend of type 1 diabetes incidence in the pediatric population of the Calabria region in 2019\u20132021. Ital J Pediatr 48:66. https:\/\/doi.org\/10.1186\/s13052-022-01264-z","journal-title":"Ital J Pediatr"},{"key":"2776_CR29","doi-asserted-by":"publisher","first-page":"101067","DOI":"10.1016\/j.eclinm.2021.101067","volume":"39","author":"C Mameli","year":"2021","unstructured":"Mameli C, Scaramuzza A, Macedoni M et al (2021) Type 1 diabetes onset in Lombardy region, Italy, during the COVID-19 pandemic: The double-wave occurrence. EClinicalMedicine 39:101067. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101067","journal-title":"EClinicalMedicine"},{"key":"2776_CR30","doi-asserted-by":"publisher","first-page":"e2321281","DOI":"10.1001\/jamanetworkopen.2023.21281","volume":"6","author":"D D\u2019Souza","year":"2023","unstructured":"D\u2019Souza D, Empringham J, Pechlivanoglou P et al (2023) Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. JAMA Netw Open 6:e2321281. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.21281","journal-title":"JAMA Netw Open"},{"key":"2776_CR31","doi-asserted-by":"publisher","first-page":"1326711","DOI":"10.3389\/fimmu.2023.1326711","volume":"14","author":"JRN Lemos","year":"2024","unstructured":"Lemos JRN, Hirani K, Von Herrath M (2024) Immunological and virological triggers of type 1 diabetes: insights and implications. Front Immunol 14:1326711. https:\/\/doi.org\/10.3389\/fimmu.2023.1326711","journal-title":"Front Immunol"},{"key":"2776_CR32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/medicina59040668","volume":"59","author":"I Ogrotis","year":"2023","unstructured":"Ogrotis I, Koufakis T, Kotsa K (2023) Changes in the Global Epidemiology of Type 1 Diabetes in an Evolving Landscape of Environmental Factors: Causes, Challenges, and Opportunities. Medicina 59:668. https:\/\/doi.org\/10.3390\/medicina59040668","journal-title":"Medicina"},{"key":"2776_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fendo.2020.00078","volume":"11","author":"S Dedrick","year":"2020","unstructured":"Dedrick S, Sundaresh B, Huang Q et al (2020) The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis. Front Endocrinol 11:78. https:\/\/doi.org\/10.3389\/fendo.2020.00078","journal-title":"Front Endocrinol"},{"key":"2776_CR34","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/S0140-6736(16)30507-4","volume":"387","author":"M Rewers","year":"2016","unstructured":"Rewers M, Ludvigsson J (2016) Environmental risk factors for type 1 diabetes. Lancet 387:2340\u20132348. https:\/\/doi.org\/10.1016\/S0140-6736(16)30507-4","journal-title":"Lancet"},{"key":"2776_CR35","doi-asserted-by":"publisher","first-page":"e3075","DOI":"10.1002\/dmrr.3075","volume":"35","author":"Y Xia","year":"2019","unstructured":"Xia Y, Xie Z, Huang G, Zhou Z (2019) Incidence and trend of type 1 diabetes and the underlying environmental determinants. Diabetes Metabolism Res 35:e3075. https:\/\/doi.org\/10.1002\/dmrr.3075","journal-title":"Diabetes Metabolism Res"},{"key":"2776_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1530\/EJE-18-0515","volume":"180","author":"C Nederstigt","year":"2019","unstructured":"Nederstigt C, Uitbeijerse BS, Janssen LGM et al (2019) Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis. Eur J Endocrinol 180:135\u2013144. https:\/\/doi.org\/10.1530\/EJE-18-0515","journal-title":"Eur J Endocrinol"},{"key":"2776_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4239\/wjd.v11.i11.527","volume":"11","author":"L Frommer","year":"2020","unstructured":"Frommer L, Kahaly GJ (2020) Type 1 diabetes and associated autoimmune diseases. WJD 11:527\u2013539. https:\/\/doi.org\/10.4239\/wjd.v11.i11.527","journal-title":"WJD"},{"key":"2776_CR38","doi-asserted-by":"publisher","first-page":"5082064","DOI":"10.1155\/2024\/5082064","volume":"2024","author":"EA Grasso","year":"2024","unstructured":"Grasso EA, Chiarelli F (2024) Type 1 Diabetes and Other Autoimmune Disorders in Children. Pediatr Diabetes 2024:5082064. https:\/\/doi.org\/10.1155\/2024\/5082064","journal-title":"Pediatr Diabetes"},{"key":"2776_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/pedi.12740","volume":"19","author":"FH Mahmud","year":"2018","unstructured":"Mahmud FH, Elbarbary NS, Fr\u00f6hlich-Reiterer E et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes 19:275\u2013286. https:\/\/doi.org\/10.1111\/pedi.12740","journal-title":"Pediatr Diabetes"},{"key":"2776_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/adc.2004.056424","volume":"90","author":"O Kordonouri","year":"2005","unstructured":"Kordonouri O (2005) Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty. Arch Dis Child 90:411\u2013414. https:\/\/doi.org\/10.1136\/adc.2004.056424","journal-title":"Arch Dis Child"},{"key":"2776_CR41","doi-asserted-by":"publisher","first-page":"1496155","DOI":"10.3389\/fendo.2024.1496155","volume":"15","author":"V Herczeg","year":"2025","unstructured":"Herczeg V, Muzslay E, Czip\u00f3 D et al (2025) Increasing prevalence of thyroid autoimmunity in childhood type 1 diabetes in the pre-COVID but not during the COVID era. Front Endocrinol 15:1496155. https:\/\/doi.org\/10.3389\/fendo.2024.1496155","journal-title":"Front Endocrinol"},{"key":"2776_CR42","doi-asserted-by":"publisher","first-page":"113238","DOI":"10.1016\/j.diabres.2026.113238","volume":"236","author":"A Fontanarosa","year":"2026","unstructured":"Fontanarosa A, Iommi M, Cesanelli F et al (2026) Epidemiology of coeliac disease in children and adolescents with type 1 diabetes: a 13-year population-based study using secondary data sources. Diabetes Res Clin Pract 236:113238. https:\/\/doi.org\/10.1016\/j.diabres.2026.113238","journal-title":"Diabetes Res Clin Pract"},{"key":"2776_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jpeds.2016.11.027","volume":"182","author":"I Youngster","year":"2017","unstructured":"Youngster I, Avorn J, Belleudi V et al (2017) Antibiotic Use in Children \u2013 A Cross-National Analysis of 6 Countries. J Pediatr 182:239\u2013244e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.11.027","journal-title":"J Pediatr"},{"key":"2776_CR44","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1177\/15209156251369882","volume":"27","author":"C Royston","year":"2025","unstructured":"Royston C, Ware J, Allen JM et al (2025) Trends in Total Daily Dose and Variability of Insulin Requirements in Newly Diagnosed Children and Adolescents with Type 1 Diabetes over 48 Months. Diabetes Technol Ther 27:1008\u20131013. https:\/\/doi.org\/10.1177\/15209156251369882","journal-title":"Diabetes Technol Ther"},{"key":"2776_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-025-02569-1","author":"B Pintaudi","year":"2025","unstructured":"Pintaudi B, Bruttomesso D, Girelli A et al (2025) Italian guidelines for the treatment of type 1 diabetes. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-025-02569-1","journal-title":"Acta Diabetol"},{"key":"2776_CR46","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1159\/000543169","volume":"97","author":"E Cengiz","year":"2024","unstructured":"Cengiz E, Danne T, Ahmad T et al (2024) International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes. Horm Res Paediatr 97:584\u2013614. https:\/\/doi.org\/10.1159\/000543169","journal-title":"Horm Res Paediatr"},{"key":"2776_CR47","doi-asserted-by":"publisher","unstructured":"Soos B, Williamson T, McBrien K et al (2025) Considerations for selecting and implementing comorbidity indices when using secondary data sources: a guide for health researchers. https:\/\/doi.org\/10.23889\/ijpds.v10i3.2973. IJPDS 10:","DOI":"10.23889\/ijpds.v10i3.2973"},{"key":"2776_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1399-543X.2006.00155.x","volume":"7","author":"M Abdul-Rasoul","year":"2006","unstructured":"Abdul-Rasoul M, Habib H, Al-Khouly M (2006) The honeymoon phase in children with type 1 diabetes mellitus: frequency, duration, and influential factors. Pediatr Diabetes 7:101\u2013107. https:\/\/doi.org\/10.1111\/j.1399-543X.2006.00155.x","journal-title":"Pediatr Diabetes"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02776-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02776-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-026-02776-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:03:15Z","timestamp":1792684995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-026-02776-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["2776"],"URL":"https:\/\/doi.org\/10.1007\/s00592-026-02776-4","relation":{"references":[{"id-type":"doi","id":"10.1186\/1471-2458-13-16","asserted-by":"subject"}]},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: due to acknowledgment section and funding section was incorrect in the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CT, CC and GF are employees of Sanofi. EM, RB, RC, VC, BP and GPF have received honoraria and\/or travel support from Sanofi for scientific activities unrelated to the present work. LDE, ML and VP are employees of CliCon, a contract research organization that provided analytical and\/or medical writing support for the AIDA study.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}